Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2135

1.

A Fragment of Apolipoprotein E4 Leads to the Downregulation of a CXorf56 Homologue, a Novel ER-Associated Protein, and Activation of BV2 Microglial Cells.

Pollock TB, Mack JM, Day RJ, Isho NF, Brown RJ, Oxford AE, Morrison BE, Hayden EJ, Rohn TT.

Oxid Med Cell Longev. 2019 May 6;2019:5123565. doi: 10.1155/2019/5123565. eCollection 2019.

PMID:
31198491
2.

A Versatile, Portable Intravital Microscopy Platform for Studying Beta-cell Biology In Vivo.

Reissaus CA, Piñeros AR, Twigg AN, Orr KS, Conteh AM, Martinez MM, Kamocka MM, Day RN, Tersey SA, Mirmira RG, Dunn KW, Linnemann AK.

Sci Rep. 2019 Jun 11;9(1):8449. doi: 10.1038/s41598-019-44777-0.

3.

Farmer perception of fall armyworm (Spodoptera frugiderda J.E. Smith) and farm-level management practices in Zambia.

Kansiime MK, Mugambi I, Rwomushana I, Nunda W, Lamontagne-Godwin J, Rware H, Phiri NA, Chipabika G, Ndlovu M, Day R.

Pest Manag Sci. 2019 May 31. doi: 10.1002/ps.5504. [Epub ahead of print]

PMID:
31148397
4.

Liquid laundry detergent capsules (PODS): a review of their composition and mechanisms of toxicity, and of the circumstances, routes, features, and management of exposure.

Day R, Bradberry SM, Thomas SHL, Vale JA.

Clin Toxicol (Phila). 2019 May 27:1-11. doi: 10.1080/15563650.2019.1618466. [Epub ahead of print]

PMID:
31130018
5.

Probiotics: current landscape and future horizons.

Day RL, Harper AJ, Woods RM, Davies OG, Heaney LM.

Future Sci OA. 2019 May 3;5(4):FSO391. doi: 10.4155/fsoa-2019-0004. Review.

6.

Enhanced recovery in liver surgery decreases postoperative outpatient use of opioids.

Lillemoe HA, Marcus RK, Day RW, Kim BJ, Narula N, Davis CH, Gottumukkala V, Aloia TA.

Surgery. 2019 May 15. pii: S0039-6060(19)30074-1. doi: 10.1016/j.surg.2019.02.008. [Epub ahead of print]

PMID:
31103198
7.

Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome.

Landauer MR, Harvey AJ, Kaytor MD, Day RM.

J Radiat Res. 2019 May 1;60(3):308-317. doi: 10.1093/jrr/rrz014.

8.

Controlling nanoemulsion surface chemistry with poly(2-oxazoline) amphiphiles.

Estabrook DA, Ennis AF, Day RA, Sletten EM.

Chem Sci. 2019 Feb 27;10(14):3994-4003. doi: 10.1039/c8sc05735d. eCollection 2019 Apr 14.

9.

Improving adherence to urate-lowering therapy in people living with gout.

Coleshill MJ, Aung E, Nguyen AD, Stocker SL, Baysari MT, Kamel B, Schulz M, McLachlan AJ, Day RO.

Int J Rheum Dis. 2019 Apr;22(4):542-544. doi: 10.1111/1756-185X.13566. No abstract available.

PMID:
30985997
10.

Do user preferences align with human factors assessment scores of drug-drug interaction alerts?

Lowenstein D, Zheng WY, Burke R, Kenny E, Sandhu A, Makeham M, Westbrook J, Day RO, Baysari MT.

Health Informatics J. 2019 Apr 11:1460458219840210. doi: 10.1177/1460458219840210. [Epub ahead of print]

PMID:
30973280
11.

Restarting antidepressant and antipsychotic medication after intentional overdoses: need for evidence-based guidance.

Tay E, Sotiriou A, Graham GG, Wilhelm K, Snowden L, Day RO.

Ther Adv Psychopharmacol. 2019 Mar 29;9:2045125319836889. doi: 10.1177/2045125319836889. eCollection 2019. Review.

12.

The impact of holding stressors on the immune function and haemolymph biochemistry of Southern Rock Lobsters (Jasus edwardsii).

Day RD, Fitzgibbon QP, Gardner C.

Fish Shellfish Immunol. 2019 Jun;89:660-671. doi: 10.1016/j.fsi.2019.03.043. Epub 2019 Mar 20.

PMID:
30902723
13.

The association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM study.

Nyitray AG, Peng F, Day RS, Carvalho Da Silva RJ, Baggio ML, Salmerón J, Quiterio M, Abrahamsen M, Lazcano-Ponce E, Villa LL, Giuliano AR.

Hum Vaccin Immunother. 2019 Mar 21:1-9. doi: 10.1080/21645515.2019.1593083. [Epub ahead of print]

PMID:
30897017
14.

A review of 4652 exposures to liquid laundry detergent capsules reported to the United Kingdom National Poisons Information Service 2008-2018.

Day R, Bradberry SM, Jackson G, Lupton DJ, Sandilands EA, H L Thomas S, Thompson JP, Vale JA.

Clin Toxicol (Phila). 2019 Mar 20:1-8. doi: 10.1080/15563650.2019.1590586. [Epub ahead of print]

PMID:
30892959
15.

Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.

Broeker A, Nardecchia M, Klinker KP, Derendorf H, Day RO, Marriott DJ, Carland JE, Stocker SL, Wicha SG.

Clin Microbiol Infect. 2019 Mar 11. pii: S1198-743X(19)30097-7. doi: 10.1016/j.cmi.2019.02.029. [Epub ahead of print]

PMID:
30872102
16.

Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection.

Darley DR, Carlos L, Hennig S, Liu Z, Day R, Glanville AR.

Eur J Clin Pharmacol. 2019 Mar 12. doi: 10.1007/s00228-019-02658-5. [Epub ahead of print]

PMID:
30859243
17.

Treatment of Facial Lipoatrophy Secondary to Subcutaneous Panniculitis-Like T-Cell Lymphoma.

Yan BY, Hibler BP, Day RA, Myskowski PL, Rossi AM.

Dermatol Surg. 2019 Feb 15. doi: 10.1097/DSS.0000000000001862. [Epub ahead of print] No abstract available.

PMID:
30829756
18.

Enhanced recovery in liver surgery.

Day RW, Aloia TA.

J Surg Oncol. 2019 Apr;119(5):660-666. doi: 10.1002/jso.25420. Epub 2019 Feb 25. Review.

PMID:
30802314
19.

Paracetamol versus placebo for knee and hip osteoarthritis.

Leopoldino AO, Machado GC, Ferreira PH, Pinheiro MB, Day R, McLachlan AJ, Hunter DJ, Ferreira ML.

Cochrane Database Syst Rev. 2019 Feb 25;2:CD013273. doi: 10.1002/14651858.CD013273.

PMID:
30801133
20.

Sleep, Obesity, and Injury Among US Male Career Firefighters.

Kaipust CM, Jahnke SA, Poston WSC, Jitnarin N, Haddock CK, Delclos GL, Day RS.

J Occup Environ Med. 2019 Apr;61(4):e150-e154. doi: 10.1097/JOM.0000000000001559.

PMID:
30789448
21.

Evaluation of Sample Preparation Methods for the Analysis of Reef-Building Corals Using ¹H-NMR-Based Metabolomics.

Andersson ER, Day RD, Loewenstein JM, Woodley CM, Schock TB.

Metabolites. 2019 Feb 13;9(2). pii: E32. doi: 10.3390/metabo9020032.

22.

Delayed Captopril Administration Mitigates Hematopoietic Injury in a Murine Model of Total Body Irradiation.

McCart EA, Lee YH, Jha J, Mungunsukh O, Rittase WB, Summers TA Jr, Muir J, Day RM.

Sci Rep. 2019 Feb 18;9(1):2198. doi: 10.1038/s41598-019-38651-2.

23.

Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug.

Kwiatkowska A, Couture F, Ait-Mohand S, Desjardins R, Dory YL, Guérin B, Day R.

Sci Rep. 2019 Feb 14;9(1):2118. doi: 10.1038/s41598-018-37568-6.

24.

Phenotype of CM-AVM2 caused by variants in EPHB4: how much overlap with hereditary hemorrhagic telangiectasia (HHT)?

Wooderchak-Donahue WL, Akay G, Whitehead K, Briggs E, Stevenson DA, O'Fallon B, Velinder M, Farrell A, Shen W, Bedoukian E, Skrabann CM, Antaya RJ, Henderson K, Pollak J, Treat J, Day R, Jacher JE, Hannibal M, Bontempo K, Marth G, Bayrak-Toydemir P, McDonald J.

Genet Med. 2019 Feb 14. doi: 10.1038/s41436-019-0443-z. [Epub ahead of print]

PMID:
30760892
25.

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors.

Conroy JM, Pabla S, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Andreas J, Giamo V, Wang Y, Lenzo FL, Bshara W, Khalil M, Dy GK, Madden KG, Shirai K, Dragnev K, Tafe LJ, Zhu J, Labriola M, Marin D, McCall SJ, Clarke J, George DJ, Zhang T, Zibelman M, Ghatalia P, Araujo-Fernandez I, de la Cruz-Merino L, Singavi A, George B, MacKinnon AC, Thompson J, Singh R, Jacob R, Kasuganti D, Shah N, Day R, Galluzzi L, Gardner M, Morrison C.

J Immunother Cancer. 2019 Jan 24;7(1):18. doi: 10.1186/s40425-018-0489-5.

26.

Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Milder TY, Stocker SL, Abdel Shaheed C, McGrath-Cadell L, Samocha-Bonet D, Greenfield JR, Day RO.

J Clin Med. 2019 Jan 4;8(1). pii: E45. doi: 10.3390/jcm8010045. Review.

27.

Early development of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network.

Buchbinder R, Bourne A, Latimer J, Harris I, Whittle S, Richards B, Taylor WJ, Clavisi O, Green S, Hinman RS, March L, Day R, Ferreira ML, Billot L, Maher CG; ANZMUSC Clinical Trial Network.

Intern Med J. 2018 Dec 11. doi: 10.1111/imj.14191. [Epub ahead of print] Review.

PMID:
30548385
28.

Improving the Selectivity of PACE4 Inhibitors through Modifications of the P1 Residue.

Dianati V, Navals P, Couture F, Desjardins R, Dame A, Kwiatkowska A, Day R, Dory YL.

J Med Chem. 2018 Dec 27;61(24):11250-11260. doi: 10.1021/acs.jmedchem.8b01381. Epub 2018 Dec 13.

PMID:
30501188
29.

Evaluation of Clinical Relevance of Drug-Drug Interaction Alerts Prior to Implementation.

Meslin SMM, Zheng WY, Day RO, Tay EMY, Baysari MT.

Appl Clin Inform. 2018 Oct;9(4):849-855. doi: 10.1055/s-0038-1676039. Epub 2018 Nov 28.

PMID:
30485879
30.

Transcriptome Profiling of Layer 5 Intratelencephalic Projection Neurons From the Mature Mouse Motor Cortex.

Clare AJ, Day RC, Empson RM, Hughes SM.

Front Mol Neurosci. 2018 Nov 12;11:410. doi: 10.3389/fnmol.2018.00410. eCollection 2018.

31.

Radiation resistance of normal human astrocytes: the role of non-homologous end joining DNA repair activity.

Bylicky MA, Mueller GP, Day RM.

J Radiat Res. 2019 Jan 1;60(1):37-50. doi: 10.1093/jrr/rry084.

PMID:
30423138
32.

Evaluation of PACE4 isoforms as biomarkers in thyroid cancer.

Fradet L, Temmar R, Couture F, Belzile M, Fortier PH, Day R.

J Otolaryngol Head Neck Surg. 2018 Oct 19;47(1):63. doi: 10.1186/s40463-018-0311-x.

33.

mHealth App Patient Testing and Review of Educational Materials Designed for Self-Management of Gout Patients: Descriptive Qualitative Studies.

Nguyen AD, Frensham LJ, Wong MX, Meslin SM, Martin P, Lau AY, Baysari MT, Day RO.

JMIR Mhealth Uhealth. 2018 Oct 15;6(10):e182. doi: 10.2196/mhealth.9811.

34.

HIV-Nef Protein Persists in the Lungs of Aviremic Patients with HIV and Induces Endothelial Cell Death.

Chelvanambi S, Bogatcheva NV, Bednorz M, Agarwal S, Maier B, Alves NJ, Li W, Syed F, Saber MM, Dahl N, Lu H, Day RB, Smith P, Jolicoeur P, Yu Q, Dhillon NK, Weissmann N, Twigg Iii HL, Clauss M.

Am J Respir Cell Mol Biol. 2019 Mar;60(3):357-366. doi: 10.1165/rcmb.2018-0089OC.

PMID:
30321057
35.

Steady State Hydration Levels of Career Firefighters in a Large, Population-Based Sample.

Suminski RR, Poston WSC, Day RS, Jitnarin N, Haddock CK, Jahnke SA, Dominick GM.

J Occup Environ Med. 2019 Jan;61(1):47-50. doi: 10.1097/JOM.0000000000001469.

PMID:
30308620
36.

Reliability, ease of use and usefulness of I-MeDeSA for evaluating drug-drug interaction alerts in an Australian context.

Baysari MT, Lowenstein D, Zheng WY, Day RO.

BMC Med Inform Decis Mak. 2018 Oct 5;18(1):83. doi: 10.1186/s12911-018-0666-y.

37.

Lactic Acidosis, Metformin Use, and Dose-Response Association.

Carland JE, Smith FC, Day RO.

JAMA Intern Med. 2018 Oct 1;178(10):1428-1429. doi: 10.1001/jamainternmed.2018.4448. No abstract available.

PMID:
30285133
38.

Mouse Mast Cell Protease 4 Deletion Protects Heart Function and Survival After Permanent Myocardial Infarction.

Houde M, Schwertani A, Touil H, Desbiens L, Sarrhini O, Lecomte R, Lepage M, Gagnon H, Takai S, Pejler G, Jacques D, Gobeil F Jr, Day R, D'Orléans-Juste P.

Front Pharmacol. 2018 Aug 31;9:868. doi: 10.3389/fphar.2018.00868. eCollection 2018.

39.

Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines.

Dianati V, Kwiatkowska A, Couture F, Desjardins R, Dory YL, Day R.

J Med Chem. 2018 Sep 27;61(18):8457-8467. doi: 10.1021/acs.jmedchem.8b01144. Epub 2018 Sep 17.

PMID:
30180568
40.

Influence of Spin-Orbit Coupling in Iron-Based Superconductors.

Day RP, Levy G, Michiardi M, Zwartsenberg B, Zonno M, Ji F, Razzoli E, Boschini F, Chi S, Liang R, Das PK, Vobornik I, Fujii J, Hardy WN, Bonn DA, Elfimov IS, Damascelli A.

Phys Rev Lett. 2018 Aug 17;121(7):076401. doi: 10.1103/PhysRevLett.121.076401.

PMID:
30169095
41.

FDA Public Meeting Report on "Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications".

Akbar M, Berry-Bibee E, Blithe DL, Day RS, Edelman A, Höchel J, Jamshidi R, Kim MJ, Li L, Purohit VS, Turpin JA, Scott PE, Strauss DG, Sun H, Tepper NK, Zhang L, Yu C.

J Clin Pharmacol. 2018 Dec;58(12):1655-1665. doi: 10.1002/jcph.1285. Epub 2018 Aug 24.

PMID:
30144093
42.

An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy.

Imani S, Buscher H, Day R, Gentili S, Jones GRD, Marriott D, Norris R, Sandaradura I.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2171-2175. doi: 10.1007/s10096-018-3357-9. Epub 2018 Aug 17.

PMID:
30120647
43.

What Do Providers Want from a Pain Screening Measure Used in Daily Practice?

Giannitrapani KF, Day RT, Azarfar A, Ahluwalia SC, Dobscha S, Lorenz KA.

Pain Med. 2019 Jan 1;20(1):68-76. doi: 10.1093/pm/pny135.

PMID:
30085285
44.

Barriers and facilitators of appropriate vancomycin use: prescribing context is key.

Chan JOS, Baysari MT, Carland JE, Sandaradura I, Moran M, Day RO.

Eur J Clin Pharmacol. 2018 Nov;74(11):1523-1529. doi: 10.1007/s00228-018-2525-2. Epub 2018 Jul 28.

PMID:
30056569
45.

Usability of Reports Generated by a Computerised Dose Prediction Software.

Baysari M, Chan J, Carland J, Stocker S, Moran M, Day R.

Stud Health Technol Inform. 2018;252:27-32.

PMID:
30040678
46.

Chronic debilitation in stranded loggerhead sea turtles (Caretta caretta) in the southeastern United States: Morphometrics and clinicopathological findings.

Stacy NI, Lynch JM, Arendt MD, Avens L, Braun McNeill J, Cray C, Day RD, Harms CA, Lee AM, Peden-Adams MM, Thorvalson K, Segars AL, Norton TM.

PLoS One. 2018 Jul 10;13(7):e0200355. doi: 10.1371/journal.pone.0200355. eCollection 2018.

47.

Captopril mitigates splenomegaly and myelofibrosis in the Gata1low murine model of myelofibrosis.

Corey SJ, Jha J, McCart EA, Rittase WB, George J, Mattapallil JJ, Mehta H, Ognoon M, Bylicky MA, Summers TA, Day RM.

J Cell Mol Med. 2018 Sep;22(9):4274-4282. doi: 10.1111/jcmm.13710. Epub 2018 Jul 4.

48.

Climate and plant controls on soil organic matter in coastal wetlands.

Osland MJ, Gabler CA, Grace JB, Day RH, McCoy ML, McLeod JL, From AS, Enwright NM, Feher LC, Stagg CL, Hartley SB.

Glob Chang Biol. 2018 Nov;24(11):5361-5379. doi: 10.1111/gcb.14376. Epub 2018 Jul 29.

PMID:
29957880
49.

Continence technologies whitepaper: Informing new engineering science research.

Culmer P, Alazmani A, Bryant M, Mancuso E, King S, Mapunde V, Jeays-Ward K, Heron N, Pearson R, Vollebregt PF, Corner L, Day R.

Proc Inst Mech Eng H. 2019 Jan;233(1):138-153. doi: 10.1177/0954411918784073. Epub 2018 Jun 27. Review.

50.

Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM).

Kumar SS, McManus H, Radovich T, Greenfield JR, Viardot A, Williams KM, Cronin P, Day RO.

Eur J Clin Pharmacol. 2018 Oct;74(10):1327-1332. doi: 10.1007/s00228-018-2506-5. Epub 2018 Jun 24.

PMID:
29938343

Supplemental Content

Support Center